• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左心疾病相关性肺动脉高压。

Pulmonary hypertension with left-sided heart disease.

机构信息

Cardiopulmonary Unit, University of Milan, San Paolo Hospital, Via A. di Rudinì 8, 20142 Milan, Italy.

出版信息

Nat Rev Cardiol. 2010 Nov;7(11):648-59. doi: 10.1038/nrcardio.2010.144. Epub 2010 Oct 5.

DOI:10.1038/nrcardio.2010.144
PMID:20924360
Abstract

Pulmonary hypertension (PH) with left-sided heart disease is defined, according to the latest Venice classification, as a Group 2 PH, which includes left-sided ventricular or atrial disease, and left-sided valvular diseases. These conditions are all associated with increased left ventricular filling pressure. Although PH with left-sided heart disease is a common entity, and long-term follow-up trials have provided firm recognition that development of left-sided PH carries a poor outcome, available data on incidence, pathophysiology, and therapy are sparse. Mitral stenosis was reported as the most frequent cause of PH several decades ago, but PH with left-sided heart disease is now usually caused by systemic hypertension and ischemic heart disease. In patients with these conditions, PH develops as a consequence of impaired left ventricular relaxation and distensibility. Chronic sustained elevation of cardiogenic blood pressure in pulmonary capillaries leads to a cascade of untoward retrograde anatomical and functional effects that represent specific targets for therapeutic intervention. The pathophysiological and clinical importance of the hemodynamic consequences of left-sided heart disease, starting with lung capillary injury and leading to right ventricular overload and failure, are discussed in this Review, focusing on PH as an evolving contributor to heart failure that may be amenable to novel interventions.

摘要

左心疾病相关肺动脉高压(PH)根据最新的威尼斯分类被定义为 2 型 PH,包括左心室或心房疾病以及左心瓣膜疾病。这些情况均与左心室充盈压升高相关。尽管左心疾病相关 PH 较为常见,且长期随访试验明确了左心 PH 进展与不良预后相关,但目前有关其发病率、病理生理学和治疗的数据仍然有限。数十年前曾报道二尖瓣狭窄是 PH 的最常见病因,但现在左心疾病相关 PH 通常由系统性高血压和缺血性心脏病引起。在这些情况下,PH 的发生是由于左心室舒张和顺应性受损所致。心源性血压在肺毛细血管中持续慢性升高,导致一系列不利的逆行解剖和功能效应,这些效应代表了治疗干预的特定靶点。本文综述了左心疾病血流动力学后果的病理生理学和临床重要性,从肺毛细血管损伤开始,导致右心室负荷过重和衰竭,并重点讨论了 PH 作为心力衰竭的一种进展性病因,可能适合新的干预措施。

相似文献

1
Pulmonary hypertension with left-sided heart disease.左心疾病相关性肺动脉高压。
Nat Rev Cardiol. 2010 Nov;7(11):648-59. doi: 10.1038/nrcardio.2010.144. Epub 2010 Oct 5.
2
Epidemiology of pulmonary hypertension and right ventricular failure in left heart failure.左心衰竭中肺动脉高压和右心室衰竭的流行病学
Curr Heart Fail Rep. 2014 Dec;11(4):428-35. doi: 10.1007/s11897-014-0216-6.
3
Pulmonary hypertension associated with left-sided heart disease.与左心疾病相关的肺动脉高压。
Heart Fail Clin. 2012 Jul;8(3):447-59. doi: 10.1016/j.hfc.2012.04.009. Epub 2012 May 18.
4
Pulmonary hypertension and right ventricular failure. Part VI. Classification and pathomorphology of primary pulmonary arterial hypertension.肺动脉高压与右心室衰竭。第六部分。原发性肺动脉高压的分类与病理形态学。
Kardiologiia. 2007;47(1):75-81.
5
Management of pulmonary hypertension in left heart disease.左心疾病中肺动脉高压的管理
Ther Adv Cardiovasc Dis. 2013 Jun;7(3):131-51. doi: 10.1177/1753944713477518. Epub 2013 Apr 16.
6
Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart.右心室起搏改善实验性肺动脉高压中的右心功能:离体心脏研究
Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1752-9. doi: 10.1152/ajpheart.00555.2009. Epub 2009 Sep 4.
7
Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction.肺动脉高压在肺静脉压升高和射血分数保留患者中的患病率和危险因素。
Am J Cardiol. 2010 Jul 15;106(2):284-6. doi: 10.1016/j.amjcard.2010.02.039.
8
Identification of Pulmonary Hypertension Caused by Left-Sided Heart Disease (World Health Organization Group 2) Based on Cardiac Chamber Volumes Derived From Chest CT Imaging.基于胸部 CT 成像得出的心脏腔室容积识别由左侧心脏疾病引起的肺动脉高压(世界卫生组织第 2 组)。
Chest. 2017 Oct;152(4):792-799. doi: 10.1016/j.chest.2017.04.184. Epub 2017 May 12.
9
Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure.肺动脉高压与右心衰竭的全身影响。
Circulation. 2020 Feb 25;141(8):678-693. doi: 10.1161/CIRCULATIONAHA.116.022362. Epub 2020 Feb 24.
10
Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.左心疾病所致肺动脉高压的临床表型和结局:毛细血管前成分的作用。
PLoS One. 2018 Jun 19;13(6):e0199164. doi: 10.1371/journal.pone.0199164. eCollection 2018.

引用本文的文献

1
Long-Term Outcomes of Mitral Valve Repair With Artificial Chordae and Annuloplasty for Myxomatous Mitral Valve Disease in Dogs.犬黏液瘤性二尖瓣疾病人工腱索和瓣环成形术二尖瓣修复的长期结果
J Vet Intern Med. 2025 Jul-Aug;39(4):e70171. doi: 10.1111/jvim.70171.
2
Endothelial cell-selective adhesion molecule deficiency exhibits increased pulmonary vascular resistance due to impaired endothelial nitric oxide signaling.内皮细胞选择性黏附分子缺乏症由于内皮型一氧化氮信号传导受损而表现出肺血管阻力增加。
Am J Physiol Heart Circ Physiol. 2025 Feb 1;328(2):H283-H293. doi: 10.1152/ajpheart.00593.2024. Epub 2024 Dec 31.
3

本文引用的文献

1
Long-term reverse remodeling with cardiac resynchronization therapy: results of extended echocardiographic follow-up.心脏再同步治疗的长期逆向重构:超声心动图随访延长的结果。
J Am Coll Cardiol. 2010 Apr 27;55(17):1788-95. doi: 10.1016/j.jacc.2010.01.022.
2
Heart failure with preserved ejection fraction: invasive solution to diagnostic confusion?射血分数保留的心力衰竭:解决诊断困惑的侵入性方法?
J Am Coll Cardiol. 2010 Apr 20;55(16):1711-2. doi: 10.1016/j.jacc.2009.12.034.
3
The relationship of right- and left-sided filling pressures in patients with heart failure and a preserved ejection fraction.
Subpulmonary ventricular function and inflammation are related to clinical heart failure in patients with a systemic right ventricle.
在系统性右心室患者中,肺动脉下心室功能和炎症与临床心力衰竭相关。
Int J Cardiol Congenit Heart Dis. 2024 Jul 31;17:100535. doi: 10.1016/j.ijcchd.2024.100535. eCollection 2024 Sep.
4
Cardiomyopathy characterizing and heart failure risk predicting by echocardiography and pathoanatomy in aged male mice.超声心动图和病理解剖学在老年雄性小鼠中心肌病特征及心力衰竭风险预测中的作用。
Physiol Rep. 2024 Oct;12(20):e70061. doi: 10.14814/phy2.70061.
5
Phosphoproteomics analysis of serum from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease.犬退行性二尖瓣疾病继发肺动脉高压症血清的磷酸蛋白质组学分析。
PeerJ. 2024 Apr 30;12:e17186. doi: 10.7717/peerj.17186. eCollection 2024.
6
Clinical-imaging-pathological correlation in pulmonary hypertension associated with left heart disease.左心疾病相关肺动脉高压的临床-影像-病理相关性。
Eur Respir Rev. 2024 Feb 28;33(171). doi: 10.1183/16000617.0144-2023. Print 2024 Jan 31.
7
Therapeutic Potential of Select Dietary Compounds in the Management of Hypertension and its Cardiovascular Complications.特定膳食化合物在高血压及其心血管并发症管理中的治疗潜力
Molecules. 2022 Oct 25;27(21):7222. doi: 10.3390/molecules27217222.
8
Factors related to survival time in dogs with pulmonary hypertension secondary to degenerative mitral valve disease stage C.继发于退行性二尖瓣疾病C期的犬肺动脉高压的生存时间相关因素。
Int J Vet Sci Med. 2022 Apr 29;10(1):25-32. doi: 10.1080/23144599.2022.2067630. eCollection 2022.
9
Protective Effects of Curcumin on Pulmonary Arterial Hypertension.姜黄素对肺动脉高压的保护作用。
Adv Exp Med Biol. 2021;1328:213-221. doi: 10.1007/978-3-030-73234-9_14.
10
Unmasking of left heart dilation following treatment for precapillary pulmonary hypertension.治疗毛细血管前性肺动脉高压后左心扩张的解除。
Can Vet J. 2021 Nov;62(11):1177-1180.
心力衰竭和射血分数保留患者右侧和左侧充盈压的关系。
Circ Heart Fail. 2010 Mar;3(2):202-6. doi: 10.1161/CIRCHEARTFAILURE.108.876649.
4
Pulmonary hypertension associated with left ventricular diastolic dysfunction.与左心室舒张功能障碍相关的肺动脉高压。
J Heart Lung Transplant. 2010 Feb;29(2):230-1. doi: 10.1016/j.healun.2009.07.014.
5
Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure.右心室射血分数对慢性收缩性心力衰竭结局的影响。
Circulation. 2010 Jan 19;121(2):252-8. doi: 10.1161/CIRCULATIONAHA.109.887570. Epub 2010 Jan 4.
6
Clinical use of phosphodiesterase-5 inhibitors in chronic heart failure.磷酸二酯酶-5抑制剂在慢性心力衰竭中的临床应用。
Circ Heart Fail. 2008 Nov;1(4):272-80. doi: 10.1161/CIRCHEARTFAILURE.108.802116.
7
Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone.心力衰竭中通气效率的决定因素:右心室功能和肺血管张力的作用。
Circ Heart Fail. 2008 Nov;1(4):227-33. doi: 10.1161/CIRCHEARTFAILURE.108.785501.
8
PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support.磷酸二酯酶5A抑制剂治疗机械循环支持后持续性肺动脉高压
Circ Heart Fail. 2008 Nov;1(4):213-9. doi: 10.1161/CIRCHEARTFAILURE.108.796789.
9
Pulmonary hypertension in heart failure with preserved ejection fraction any pathophysiological role of mitral regurgitation.射血分数保留的心力衰竭中的肺动脉高压:二尖瓣反流的任何病理生理作用。
J Am Coll Cardiol. 2009 Sep 22;54(13):1191-2; author reply 1192. doi: 10.1016/j.jacc.2009.04.088.
10
Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil.心力衰竭和肺动脉高压中经肺B型利钠肽摄取及环磷酸鸟苷释放:西地那非的作用
J Am Coll Cardiol. 2009 Aug 11;54(7):595-600. doi: 10.1016/j.jacc.2009.05.021.